IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy
Authors
Keywords
-
Journal
BMC INFECTIOUS DISEASES
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2011-05-20
DOI
10.1186/1471-2334-11-135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
- (2013) Madhukar Pai et al. ANNALS OF INTERNAL MEDICINE
- Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children
- (2010) Tom G Connell et al. BMC INFECTIOUS DISEASES
- IP-10 detection in urine is associated with lung diseases
- (2010) Angela Cannas et al. BMC INFECTIOUS DISEASES
- A 100 year update on diagnosis of tuberculosis infection
- (2010) A. Lalvani et al. BRITISH MEDICAL BULLETIN
- Potential of interferon- -inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients
- (2010) M. G. Aabye et al. EUROPEAN RESPIRATORY JOURNAL
- IFN-γ, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis
- (2010) Delia Goletti et al. JOURNAL OF INFECTION
- Role of QuantiFERON-TB Gold, Interferon Gamma Inducible Protein-10 and Tuberculin Skin Test in Active Tuberculosis Diagnosis
- (2010) Basirudeen Syed Ahamed Kabeer et al. PLoS One
- Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?
- (2010) Delia Goletti et al. PLoS One
- Advances in the diagnosis of tuberculosis
- (2010) Christoph LANGE et al. RESPIROLOGY
- Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV–tuberculosis patients
- (2009) Basirudeen SA Kabeer et al. AIDS
- T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings
- (2009) Keertan Dheda et al. CURRENT OPINION IN PULMONARY MEDICINE
- In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response
- (2009) Ilaria Sauzullo et al. PLoS One
- Response to M. tuberculosisselected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study
- (2008) Delia Goletti et al. BMC INFECTIOUS DISEASES
- T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment
- (2008) Jose Domínguez et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
- (2008) M. Ruhwald et al. EUROPEAN RESPIRATORY JOURNAL
- Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment
- (2008) Yoshihiro Kobashi et al. JOURNAL OF INFECTION
- Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study
- (2008) Delia Goletti et al. PLoS One
- Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFNγ?
- (2008) Elizabeth Whittaker et al. PLoS One
- Do results of the T-SPOT.TB interferon-γ release assay change after treatment of tuberculosis?
- (2008) Valerie Bosshard et al. RESPIRATORY MEDICINE
- Interferon-γ responses after isoniazid chemotherapy for latent tuberculosis
- (2008) Kazue HIGUCHI et al. RESPIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started